aAbs |
Autoantibodies |
ACPA |
Anti-citrullinated protein antibody |
ADCC |
Antibody-dependent cell cytotoxicity |
ADCP |
Antibody-dependent cell phagocytosis |
AGEs |
Advanced glycation end products |
CDC |
Complement-dependent cytotoxicity |
CVD |
Cardiovascular disease |
CEL |
Nε-(carboxyethyl) lysine |
CDRs |
Complementarity-determining regions |
CIA |
Collagen-induced arthritis |
CRP |
C-reactive protein |
CVC |
Cardiovascular complications |
CVD |
Cardiovascular disease |
DC |
Dendritic cells |
EBA |
Epidermolysis of bullosa acquisita |
ECs |
Endothelial cells |
Ig |
Immunoglobulin |
IVIg |
Intravenous immunoglobulin |
IL |
Interleukin |
ICs |
Immune complexes |
ITP |
Thrombocytopenic purpura |
HIV |
Human immunodeficiency virus |
LPS |
Lipopolysaccharide |
MBL |
Mannose-binding lectin |
MG |
Methylglyoxal |
PHA |
Phytohemagglutinin |
pDCs |
Plasmacytoid dendritic cells |
RA |
Rheumatoid arthritis |
sVCAM-1 |
Soluble vascular cellular activation molecule 1 |
SpA |
Spondyloarthropathy |
TG |
Triglyceride |
TLA |
Three letter acronymn |
TNF |
Tumor necrosis factor |
VLDL |
Very low-density lipoprotein |